American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$233M |
| 2 |
Workday
WDAY
|
+$177M |
| 3 |
Eli Lilly
LLY
|
+$174M |
| 4 |
Apple
AAPL
|
+$171M |
| 5 |
Agree Realty
ADC
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$486M |
| 2 |
Colgate-Palmolive
CL
|
+$230M |
| 3 |
NXP Semiconductors
NXPI
|
+$192M |
| 4 |
Merck
MRK
|
+$172M |
| 5 |
Duke Energy
DUK
|
+$170M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.52% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 11.51% |
| 4 | Healthcare | 11.17% |
| 5 | Industrials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
RingCentral
RNG
$5.66B
| $1.08M | ﹤0.01% |
34,105
-4,517
| -12% | -$143K |
|
2202
New Jersey Resources
NJR
$5.64B
| $1.08M | ﹤0.01% |
22,823
+1,642
| +8% | +$75K |
|
|
LINE
2203
Lineage Inc
LINE
$9.8B
| $1.08M | ﹤0.01% |
+13,727
| New | +$1.15M |
|
2204
Integra LifeSciences
IART
$1.42B
| $1.08M | ﹤0.01% |
59,166
-21,141
| -26% | -$490K |
|
2205
The ONE Group
STKS
$56.8M
| $1.07M | ﹤0.01% |
291,843
-15,998
| -5% | -$64.3K |
|
2206
MannKind Corp
MNKD
$1.2B
| $1.07M | ﹤0.01% |
170,079
+147,470
| +652% | +$847K |
|
2207
UGI
UGI
$7.56B
| $1.06M | ﹤0.01% |
42,412
-146,465
| -78% | -$3.53M |
|
2208
Prestige Consumer Healthcare
PBH
$2.43B
| $1.06M | ﹤0.01% |
14,707
+400
| +3% | +$28.3K |
|
|
ALE
2209
DELISTED
Allete
ALE
| $1.06M | ﹤0.01% |
16,442
-113,275
| -87% | -$7.21M |
|
|
RNAM
2210
DELISTED
Avidity Biosciences
RNAM
| $1.05M | ﹤0.01% |
22,844
-141,787
| -86% | -$6.15M |
|
2211
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $1.05M | ﹤0.01% |
41,870
+12,644
| +43% | +$308K |
|
2212
Compass Minerals
CMP
$1.1B
| $1.05M | ﹤0.01% |
87,048
+10,810
| +14% | +$115K |
|
2213
Investar Holding Corp
ISTR
$425M
| $1.04M | ﹤0.01% |
53,720
+41,899
| +354% | +$737K |
|
2214
Aurora
AUR
$13.4B
| $1.04M | ﹤0.01% |
174,966
+16,216
| +10% | +$67.6K |
|
|
SWI
2215
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.03M | ﹤0.01% |
79,149
+14,714
| +23% | +$181K |
|
|
SOHU
2216
Sohu.com
SOHU
$364M
| $1.03M | ﹤0.01% |
65,407
+16,752
| +34% | +$252K |
|
2217
GlobalFoundries
GFS
$28.9B
| $1.03M | ﹤0.01% |
25,511
+923
| +4% | +$42.8K |
|
2218
Cytek Biosciences
CTKB
$636M
| $1.02M | ﹤0.01% |
184,943
+30,004
| +19% | +$170K |
|
2219
Oric Pharmaceuticals
ORIC
$1.42B
| $1.02M | ﹤0.01% |
99,503
+15,302
| +18% | +$151K |
|
2220
Pliant Therapeutics
PLRX
$66.9M
| $1.02M | ﹤0.01% |
90,905
+16,792
| +23% | +$210K |
|
2221
Franklin Covey
FC
$227M
| $1.01M | ﹤0.01% |
24,628
+2,847
| +13% | +$114K |
|
2222
Orthofix Medical
OFIX
$415M
| $1.01M | ﹤0.01% |
64,803
+9,839
| +18% | +$158K |
|
2223
Tyra Biosciences
TYRA
$1.49B
| $1.01M | ﹤0.01% |
42,999
-127,284
| -75% | -$2.67M |
|
2224
Roivant Sciences
ROIV
$26.2B
| $1.01M | ﹤0.01% |
87,375
+5,953
| +7% | +$67.8K |
|
2225
XBiotech
XBIT
$71M
| $1.01M | ﹤0.01% |
130,183
+53,723
| +70% | +$353K |
|
Similar funds
American Century Companies's Q3 2024 Portfolio in Review
As of Q3 2024, American Century Companies held 3,003 positions worth $172B, up 5.3% from $163B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
American Century Companies's Q3 2024 filing shows 117 new, 1,782 increased, 832 reduced and 125 closed positions. Its largest new stake was Talen Energy Corp: 344,591 shares worth $61.4M. The largest sale was Visa, an estimated $486M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- American Century Companies's largest Q3 2024 buy was Talen Energy Corp: 344,591 shares worth $61.4M.
- American Century Companies added most to Broadcom in Q3 2024, an estimated $233M increase.
- American Century Companies's biggest Q3 2024 reduction was Visa, cutting an estimated $486M.
- American Century Companies fully exited Encore Wire Corp in Q3 2024, selling an estimated $106M.
- American Century Companies's ten largest holdings make up 26% of its $172B portfolio in Q3 2024.
- American Century Companies opened 117 new positions and closed 125 in Q3 2024.
- American Century Companies's portfolio value rose 5.3% quarter-over-quarter to $172B.
Based on American Century Companies's 13F filing for Q3 2024, filed 12 Nov 2024.